Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach symbols : AZNCF save search
Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -2.02%
H: 0.67%
C: 0.67%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.91%
H: 0.08%
C: -1.1%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -21.75%
art27 treatment cares trial
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -2.2%
H: 3.27%
C: 0.6%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.18%
H: 1.85%
C: 1.55%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: 2.97%
H: 5.13%
C: 4.59%
results
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia
Published: 2022-04-13 (Crawled : 13:00) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -3.19%
H: 3.22%
C: 0.54%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.04%
H: 0.84%
C: 0.57%
ARTL | News | $1.31 0.0% 5.4K
|
Health Technology
|
| O: 38.1%
H: 27.29%
C: -12.83%
pre-clinical program positive art27.13 preclinical cancer
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -4.79%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 2.03%
H: 0.66%
C: -5.96%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
cutx-101 america genetic therapeutics biotech iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.